Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunpeng Gene, officially Kunpeng Tailin (Beijing) Biotechnology Co., Ltd., is a leading Chinese molecular diagnostics company specializing in high-end quantitative PCR (qPCR) systems and automated nucleic acid extraction technology. Founded in 2016 and headquartered in Beijing's Life Science Park, the company develops integrated solutions for clinical diagnostics, life science research, and food safety. Their flagship Archimed series of qPCR instruments is known for its high sensitivity and rapid thermal cycling, supporting applications in infectious disease monitoring, oncology, and genetic screening. Kunpeng Gene's products are utilized globally in hospitals, research laboratories, and public health centers to support precision medicine and disease surveillance. The firm has established a significant presence in the IVD market through its commitment to independent R&D and manufacturing excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunpeng Tailin Biotechnology.